Annual SG&A
$17.45 M
+$2.33 M+15.39%
31 December 2023
Summary:
InflaRx NV annual selling, general & administrative expenses is currently $17.45 million, with the most recent change of +$2.33 million (+15.39%) on 31 December 2023. During the last 3 years, it has risen by +$8.42 million (+93.20%). IFRX annual SG&A is now at all-time high.IFRX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.97 M
-$475.10 K-8.73%
01 September 2024
Summary:
InflaRx NV quarterly selling, general & administrative expenses is currently $4.97 million, with the most recent change of -$475.10 thousand (-8.73%) on 01 September 2024. Over the past year, it has increased by +$111.40 thousand (+2.29%). IFRX quarterly SG&A is now -9.23% below its all-time high of $5.47 million, reached on 31 March 2024.IFRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.33 B
-$79.31 M-6.33%
01 September 2024
Summary:
InflaRx NV TTM selling, general & administrative expenses is currently -$1.33 billion, with the most recent change of -$79.31 million (-6.33%) on 01 September 2024. Over the past year, it has dropped by -$1.35 billion (-8714.89%). IFRX TTM SG&A is now -4560.29% below its all-time high of $20.45 million, reached on 01 September 2024.IFRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IFRX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.4% | +2.3% | -8714.9% |
| 3 y3 years | +93.2% | +24.1% | -10000.0% |
| 5 y5 years | +15.6% | +79.4% | -9162.0% |
IFRX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +93.2% | -9.2% | +92.7% | -53.2% | at low |
| 5 y | 5 years | at high | +93.2% | -9.2% | +264.3% | -197.7% | at low |
| alltime | all time | at high | +3491.4% | -9.2% | +1565.3% | -4560.3% | at low |
InflaRx NV Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.97 M(-8.7%) | $20.45 M(+0.5%) |
| June 2024 | - | $5.44 M(-0.6%) | $20.33 M(+6.7%) |
| Mar 2024 | - | $5.47 M(+20.0%) | $19.05 M(+9.2%) |
| Dec 2023 | $17.45 M(+15.4%) | $4.56 M(-6.0%) | $17.46 M(+12.8%) |
| Sept 2023 | - | $4.86 M(+16.7%) | $15.47 M(+12.7%) |
| June 2023 | - | $4.16 M(+7.4%) | $13.73 M(-3.3%) |
| Mar 2023 | - | $3.88 M(+50.3%) | $14.19 M(-6.9%) |
| Dec 2022 | $15.13 M(+11.8%) | $2.58 M(-17.1%) | $15.24 M(-0.5%) |
| Sept 2022 | - | $3.11 M(-32.8%) | $15.31 M(-5.5%) |
| June 2022 | - | $4.63 M(-5.9%) | $16.21 M(+9.3%) |
| Mar 2022 | - | $4.92 M(+85.8%) | $14.83 M(+9.5%) |
| Dec 2021 | $13.53 M(+49.7%) | $2.65 M(-33.8%) | $13.55 M(+3.4%) |
| Sept 2021 | - | $4.00 M(+23.1%) | $13.11 M(+25.2%) |
| June 2021 | - | $3.25 M(-10.7%) | $10.47 M(+7.0%) |
| Mar 2021 | - | $3.64 M(+64.8%) | $9.78 M(+9.1%) |
| Dec 2020 | $9.03 M | $2.21 M(+62.0%) | $8.97 M(-6.5%) |
| Sept 2020 | - | $1.36 M(-46.8%) | $9.59 M(-12.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $2.56 M(-9.5%) | $10.99 M(-12.3%) |
| Mar 2020 | - | $2.83 M(-0.1%) | $12.53 M(-6.8%) |
| Dec 2019 | $13.43 M(-11.0%) | $2.83 M(+2.3%) | $13.45 M(-8.6%) |
| Sept 2019 | - | $2.77 M(-32.4%) | $14.71 M(-5.0%) |
| June 2019 | - | $4.10 M(+9.3%) | $15.48 M(+2.1%) |
| Mar 2019 | - | $3.75 M(-8.4%) | $15.15 M(+0.4%) |
| Dec 2018 | $15.10 M(+159.5%) | $4.09 M(+15.7%) | $15.10 M(+3.0%) |
| Sept 2018 | - | $3.54 M(-6.3%) | $14.65 M(+22.8%) |
| June 2018 | - | $3.77 M(+2.2%) | $11.93 M(+33.1%) |
| Mar 2018 | - | $3.69 M(+1.1%) | $8.96 M(+51.3%) |
| Dec 2017 | $5.82 M(+185.1%) | $3.65 M(+348.8%) | $5.92 M(+89.4%) |
| Sept 2017 | - | $813.50 K(+1.1%) | $3.13 M(+7.7%) |
| June 2017 | - | $804.30 K(+22.8%) | $2.90 M(+21.1%) |
| Mar 2017 | - | $655.10 K(-23.3%) | $2.40 M(+37.6%) |
| Dec 2016 | $2.04 M(+319.9%) | $854.40 K(+45.0%) | $1.74 M(+96.3%) |
| Sept 2016 | - | $589.30 K(+97.6%) | $887.60 K(+197.6%) |
| June 2016 | - | $298.30 K | $298.30 K |
| Dec 2015 | $486.00 K | - | - |
FAQ
- What is InflaRx NV annual selling, general & administrative expenses?
- What is the all time high annual SG&A for InflaRx NV?
- What is InflaRx NV annual SG&A year-on-year change?
- What is InflaRx NV quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for InflaRx NV?
- What is InflaRx NV quarterly SG&A year-on-year change?
- What is InflaRx NV TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for InflaRx NV?
- What is InflaRx NV TTM SG&A year-on-year change?
What is InflaRx NV annual selling, general & administrative expenses?
The current annual SG&A of IFRX is $17.45 M
What is the all time high annual SG&A for InflaRx NV?
InflaRx NV all-time high annual selling, general & administrative expenses is $17.45 M
What is InflaRx NV annual SG&A year-on-year change?
Over the past year, IFRX annual selling, general & administrative expenses has changed by +$2.33 M (+15.39%)
What is InflaRx NV quarterly selling, general & administrative expenses?
The current quarterly SG&A of IFRX is $4.97 M
What is the all time high quarterly SG&A for InflaRx NV?
InflaRx NV all-time high quarterly selling, general & administrative expenses is $5.47 M
What is InflaRx NV quarterly SG&A year-on-year change?
Over the past year, IFRX quarterly selling, general & administrative expenses has changed by +$111.40 K (+2.29%)
What is InflaRx NV TTM selling, general & administrative expenses?
The current TTM SG&A of IFRX is -$1.33 B
What is the all time high TTM SG&A for InflaRx NV?
InflaRx NV all-time high TTM selling, general & administrative expenses is $20.45 M
What is InflaRx NV TTM SG&A year-on-year change?
Over the past year, IFRX TTM selling, general & administrative expenses has changed by -$1.35 B (-8714.89%)